FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791219278> ?p ?o ?g. }

• W2791219278 endingPage "1339" @default.
• W2791219278 startingPage "1327" @default.
• W2791219278 abstract "Breast cancer is the most common cancer among women. Pemetrexed, a new generation antifolate drug, is one of the primary treatments for breast cancer. However, multidrug resistance (MDR) in breast cancer greatly hampers the therapeutic efficacy of chemotherapies such as pemetrexed. Nanomedicine is emerging as a promising alternative technique to overcome cancer MDR. Thus, pemetrexed-loaded d-alpha tocopheryl polyethylene glycol 1000 succinate (vitamin E TPGS) liposomes (liposomal pemetrexed) were developed as a strategy to overcome MDR to pemetrexed in breast cancer.Liposomal pemetrexed was developed using the calcium acetate gradient method. The cytotoxic effects, apoptosis-inducing activity, in vivo distribution, and antitumor activity of liposomal pemetrexed were investigated.Liposomal pemetrexed was small in size (160.77 nm), with a small polydispersity of <0.1. The encapsulation efficacy of liposomal pemetrexed was 63.5%, which is rather high for water-soluble drugs in liposomes. The IC50 of liposomal pemetrexed following treatment with MDR breast cancer cells (MCF-7 cells overexpressing ABCC5) was 2.6-fold more effective than pemetrexed. The in vivo biodistribution study showed that the liposomes significantly accumulated in tumors 24 h after injection. The antitumor assay in mice bearing MDR breast cancer xenograft tumors confirmed the superior antitumor activity of liposomal pemetrexed over pemetrexed. It was also found that the improved therapeutic effect of liposomal pemetrexed may be attributed to apoptosis through both extrinsic and intrinsic pathways.Liposomal pemetrexed represents a potential therapeutic approach for overcoming breast cancer MDR." @default.
• W2791219278 created "2018-03-29" @default.
• W2791219278 creator A5001137728 @default.
• W2791219278 creator A5019115968 @default.
• W2791219278 creator A5024814050 @default.
• W2791219278 creator A5025250730 @default.
• W2791219278 creator A5039242472 @default.
• W2791219278 creator A5047736781 @default.
• W2791219278 creator A5057209439 @default.
• W2791219278 creator A5068731692 @default.
• W2791219278 creator A5077716269 @default.
• W2791219278 creator A5080559636 @default.
• W2791219278 date "2018-03-01" @default.
• W2791219278 modified "2023-10-17" @default.
• W2791219278 title "Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer" @default.
• W2791219278 cites W1757407923 @default.
• W2791219278 cites W1985158732 @default.
• W2791219278 cites W1990497572 @default.
• W2791219278 cites W2006434892 @default.
• W2791219278 cites W2013765163 @default.
• W2791219278 cites W2014408224 @default.
• W2791219278 cites W2022008113 @default.
• W2791219278 cites W2025492041 @default.
• W2791219278 cites W2032760352 @default.
• W2791219278 cites W2037961079 @default.
• W2791219278 cites W2062069198 @default.
• W2791219278 cites W2097603366 @default.
• W2791219278 cites W2101000241 @default.
• W2791219278 cites W2106742754 @default.
• W2791219278 cites W2112362471 @default.
• W2791219278 cites W2116632332 @default.
• W2791219278 cites W2119203526 @default.
• W2791219278 cites W2512454832 @default.
• W2791219278 doi "https://doi.org/10.2147/ijn.s150237" @default.
• W2791219278 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5846754" @default.
• W2791219278 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29563790" @default.
• W2791219278 hasPublicationYear "2018" @default.
• W2791219278 type Work @default.
• W2791219278 sameAs 2791219278 @default.
• W2791219278 citedByCount "16" @default.
• W2791219278 countsByYear W27912192782019 @default.
• W2791219278 countsByYear W27912192782020 @default.
• W2791219278 countsByYear W27912192782021 @default.
• W2791219278 countsByYear W27912192782022 @default.
• W2791219278 countsByYear W27912192782023 @default.
• W2791219278 crossrefType "journal-article" @default.
• W2791219278 hasAuthorship W2791219278A5001137728 @default.
• W2791219278 hasAuthorship W2791219278A5019115968 @default.
• W2791219278 hasAuthorship W2791219278A5024814050 @default.
• W2791219278 hasAuthorship W2791219278A5025250730 @default.
• W2791219278 hasAuthorship W2791219278A5039242472 @default.
• W2791219278 hasAuthorship W2791219278A5047736781 @default.
• W2791219278 hasAuthorship W2791219278A5057209439 @default.
• W2791219278 hasAuthorship W2791219278A5068731692 @default.
• W2791219278 hasAuthorship W2791219278A5077716269 @default.
• W2791219278 hasAuthorship W2791219278A5080559636 @default.
• W2791219278 hasBestOaLocation W27912192781 @default.
• W2791219278 hasConcept C121608353 @default.
• W2791219278 hasConcept C126322002 @default.
• W2791219278 hasConcept C185154212 @default.
• W2791219278 hasConcept C185592680 @default.
• W2791219278 hasConcept C2776694085 @default.
• W2791219278 hasConcept C2777240266 @default.
• W2791219278 hasConcept C2778239845 @default.
• W2791219278 hasConcept C502942594 @default.
• W2791219278 hasConcept C530470458 @default.
• W2791219278 hasConcept C55493867 @default.
• W2791219278 hasConcept C71924100 @default.
• W2791219278 hasConcept C98274493 @default.
• W2791219278 hasConceptScore W2791219278C121608353 @default.
• W2791219278 hasConceptScore W2791219278C126322002 @default.
• W2791219278 hasConceptScore W2791219278C185154212 @default.
• W2791219278 hasConceptScore W2791219278C185592680 @default.
• W2791219278 hasConceptScore W2791219278C2776694085 @default.
• W2791219278 hasConceptScore W2791219278C2777240266 @default.
• W2791219278 hasConceptScore W2791219278C2778239845 @default.
• W2791219278 hasConceptScore W2791219278C502942594 @default.
• W2791219278 hasConceptScore W2791219278C530470458 @default.
• W2791219278 hasConceptScore W2791219278C55493867 @default.
• W2791219278 hasConceptScore W2791219278C71924100 @default.
• W2791219278 hasConceptScore W2791219278C98274493 @default.
• W2791219278 hasLocation W27912192781 @default.
• W2791219278 hasLocation W27912192782 @default.
• W2791219278 hasLocation W27912192783 @default.
• W2791219278 hasOpenAccess W2791219278 @default.
• W2791219278 hasPrimaryLocation W27912192781 @default.
• W2791219278 hasRelatedWork W1968491853 @default.
• W2791219278 hasRelatedWork W2167650070 @default.
• W2791219278 hasRelatedWork W2371666691 @default.
• W2791219278 hasRelatedWork W2378355431 @default.
• W2791219278 hasRelatedWork W2488129137 @default.
• W2791219278 hasRelatedWork W2558365185 @default.
• W2791219278 hasRelatedWork W2606568050 @default.
• W2791219278 hasRelatedWork W3032772405 @default.
• W2791219278 hasRelatedWork W3162595500 @default.
• W2791219278 hasRelatedWork W3201348732 @default.
• W2791219278 hasVolume "Volume 13" @default.
• W2791219278 isParatext "false" @default.

• next